The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both

British Journal of Haematology

Volumn 111, Issue 4, 2000, Pages 1223-1229

  Martinelli, Ida ^a,e   Bucciarelli, Paolo ^a   Margaglione, Maurizio ^b   De Stefano, Valerio ^c   Castaman, Giancarlo ^d   Mannucci, Pier Mannuccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d SAN BORTOLO HOSPITAL   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Factor V Leiden; Prothrombin G20210A mutation; Thrombophilia; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; FEMALE; GENE MUTATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCREENING; THROMBOEMBOLISM; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MUTATION; PREVALENCE; PROTHROMBIN; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOSIS;

EID: 0034487766     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02502.x     Document Type: Article

References (30)

1. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
2. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease
3. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene
4. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency or activated protein C resistance
5. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels
6. Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C
7. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria
8. Clinical manifestations and management of inherited thrombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S
9. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
10. Anticoagulant protein C pathway defective in majority of thrombophilic patients
11. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
12. R506Q
13. A prothrombin gene mutation is significantly associated with venous thrombosis
14. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
15. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene
16. Inherited thrombophilia: Part 1
17. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients
18. Venous thrombotic risk in family members of unselected individuals with factor V Leiden
19. Prevalence of 20210A allele of the prothrombin gene in venous thromboembolism patients
20. 20210 gene variant
21. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families
22. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis
23. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
24. World distribution of factor V Leiden
25. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thromboembolism in apparently healthy men
26. Geographic distribution of the 20210 G to A prothrombin variant
27. Incidence of venous thromboembolism in families with inherited thrombophilia
28. Resistance to activated protein C as a basis for venous thrombosis
29. Validated questionnaire for the identification of previous personal or familial history of venous thromboembolism
30. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency